Coronary angiography is still the most widely used method for the assessment of lumen of coronary arteries and for diagnosis and treatment of coronary artery disease. New imaging modalities of coronary arteries play an increasing role in interventional cardiology. Intravascular ultrasound (IVUS) is the oldest technology, however due to its high tissue penetration remains very important for imaging of left main coronary artery and saphenous vein grafts.
INTRODUCTION
Coronary angiography is still the most widely used method for the assessment of lumen of coronary arteries and for diagnosis and treatment of coronary artery dis- 
OPTICAL COHERENCE TOmOgRAPHY
Optical coherence tomography (OCT) is a new, very fast evolving method in the evaluation of the internal lumen and the wall of coronary arteries. Its principle is similar to intracoronary ultrasound, which uses sound reflections. OCT uses a light source of a wavelength 1300 nm, which is near infrared light. Light emitted from the catheter is reflected by the microstructures in biological tissues and returns to the detector, which analyzes the changed wavelength of the light. Laser source is used by last OCT devices, we're talking about the so-called optical frequency domain imaging (OFDI). First OCT systems emerged in the early '90s of the last century and their use in imaging of the retina and blood vessels was assumed [1] . About ten years ago the first generation OCT was utilized only in some centers in restricted indications and only for research purposes. The need for temporary occlusion of the coronary artery by a baloon fixed to the proximal part of the OCT catheter was its main limitation.
As blood elements significantly worsen the image quality, the distal lumen of the coronary artery has to be flushed with saline and thereby the presence of red blood cells between the catheter and the vessel wall at the time of recording is minimized. These were the so-called occlusive OCT helps to assess the cause and extent of coronary artery disease, which is important not only for clinical practice but also for many research projects evaluating the process of atherosclerosis and its medical treatment.
OCT can be an integral part of complex PCI procedures with stent implantation. Like any surgical intervention, coronary stent implantation has its drawbacks and risks, and stent thrombosis is one of them. Early and late stent thromboses are distinguished. Early stent thrombosis occurs within 7 days after implantation and is caused mostly by insufficient expansion of the stent. In these cases the term "stent malapposition" is used. The status of the 
OUR EXPERIENCE
The authors examined by OCT 124 patients from January 2010 till December 2013. Seventy-six of them (61%) had a diagnosis of chronic ischemic heart disease, 38 (31%) acute myocardial infarction without ST segment elevation or unstable angina pectoris and 10 (8%) ST segment elevation myocardial infarction. The indications for OCT were: to evaluate the stent apposition and stent healing, stent thrombosis, complex PCI procedures, to define the culprit lesion in patients with acute coronary syndrome, after heart transplantation. In total we have checked 151 stents, 36 (24%) were drug eluting stents (DES), 57 (38%)
were stents with rapid endothelization and 58 (38%) were bare metal stents (BMS).
FIgURE 1.
Bare metal stent implanted to the left main -left anterior descending artery (LAD) over left circumfl ex artery (LCx) without fi nal kissing dilatation. OCT after 1 year. Small neointimal proliferation in segments 0-7, free stent struts at the ostium of LCx (segments 9-11).
FIgURE 2. Similar to IVUS, OCT can measure the inner lumen of coronary arteries and determine the signifi cance of coronary stenosis. OCT six months after implantation of a drug eluting stent (DES).
The area of inner lumen is 11.0 mm 2 , the area stenosis is 19.5%. [4, 16] . This is shown in the study done by Templin, who found differences in the optical density of fibrin and neointima that cover the stent [22] . Stent malapposition is diagnosed if we find a clear separation ≥150-200 µm between the vessel wall and the stent strut [23] . We measure the distance between the inner edge of the strut and the vessel wall plus 20-30 µm, which corrects the presence of artifacts and takes into account the axial resolution of OCT. There is no major sense to determine the coverage of malapposed struts, because they are prothrombogenic due to changes of blood flow, and because it is difficult to realize whether they are covered with fibrin or functional endothelium. All malapposed struts are regarded as potentially dangerous. Higher sensitivity for detection of neointimal hyperplasia by OCT compared to IVUS six months after implantation of bare metal and drug eluting stents was demonstrated in the Odessa trial [24] . The authors found that 92.7% of stent struts were covered with tissue, 5% were not covered and 2.3% were malapposed. No neointimal hyperplasia was seen by IVUS. The smallest strut coverage was observed in overlapping paclitaxel stents. Katoh et al. [25] found that almost 90% of sirolimus stent struts were covered after 6 months and this percentage was still increasing in the next 6 months.
Trials evaluaTing sTenT healing and sTenT coverage
Similar conclusions were reached by Li S et al. [15] ), who found a lower prevalence of uncovered and malapposed struts of zotarolimus stents compared with sirolimus and paclitaxel stents (3.0% vs 9.0% vs 6.2%; 1.7% vs 6.4% vs 2.3%) using OCT examination 12 months after implantation. The ENDEAVOR OCT study showed a low incidence of zotarolimus stent malapposition both immediately and 3 months after implantation (6.0% vs 0.2%) [26, 27] . The LEADERS trial was a randomized, multicenter study comparing healing and malapposition of biolimus stent with a biodegradable polymer to sirolimus stent with permanent polymer. The authors discovered that the percentage of uncovered struts was lower in the biolimus group [28] .
HORIZONS-OCT was a randomized study evaluating the stent coverage 13 months after acute myocardial infarction. Patients with paclitaxel stents had worse coverage but lower neointimal proliferation compared to bare metal stents [29] . The OCTAMI trial compared the coverage and malapposition of zotarolimus eluting and bare metal stents. No difference between both groups was found [30] .
There is no significant difference between OCT and IVUS in the assessment of excessive neointimal proliferation associated with development of restenosis. 
